Viridian Therapeutics Ors Inc (VRDN) returns
Viridian Therapeutics Ors returns over 10 years
$1,000 invested in Viridian Therapeutics Ors ten years ago was worth $328.97 at the close on October 30, 2026, with dividends reinvested: an average return of -10.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +19.8% | — | $1,198 | -0.9% |
| 3 months | +24.0% | — | $1,240 | +2.1% |
| Year to date | -20.7% | — | $792.74 | +11.7% |
| 1 year | +4.3% | — | $1,043 | +12.4% |
| 3 years | +89.5% | +23.7% | $1,895 | +88.5% |
| 5 years | +36.3% | +6.4% | $1,363 | +76.0% |
| 10 years | -67.1% | -10.5% | $328.97 | +316.6% |
Viridian Therapeutics Ors return by calendar year
| Year | VRDN | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -20.7% | +11.7% | -32.4% |
| 2025 | +62.3% | +17.7% | +44.6% |
| 2024 | -12.0% | +24.9% | -36.9% |
| 2023 | -25.4% | +26.2% | -51.6% |
| 2022 | +47.7% | -18.2% | +65.9% |
| 2021 | +20.2% | +28.7% | -8.6% |
| 2020 | +128.5% | +18.4% | +110.1% |
| 2019 | -84.2% | +31.2% | -115.4% |
| 2018 | -70.9% | -4.6% | -66.4% |
| 2017 | +108.2% | +21.7% | +86.5% |
| 2016 | -55.3% | +12.0% | -67.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: VRDN financials
No forecast, no recommendation. This page describes Viridian Therapeutics Ors Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.